ArticleTranslational oncology2016

BEZ235 (PIK3/mTOR inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma Cells.

Hee Kyung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.